Detection of HIV protease inhibitors in alveolar epithelial lining fluid: Relevance for modulation of Pneumocystis infection in the course of HAART

Journal of Eukaryotic Microbiology

Volumn 53, Issue SUPPL. 1, 2006, Pages

  Atzori, Chiara ^a   Villani, Paola ^b   Regazzi, Mario ^b   Mazza, Francesca ^a   Valerio, Antonella ^a   Tronconi, Elisa ^a   Maruzzi, Massimo ^a   Cargnel, Antonietta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NELFINAVIR; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRONE DERIVATIVE; RITONAVIR; SAQUINAVIR; TIPRANAVIR;

DETECTION METHOD; HUMAN IMMUNODEFICIENCY VIRUS; RESPIRATORY DISEASE;

AIDS RELATED COMPLEX; BRONCHOSCOPY; CHEMISTRY; CONFERENCE PAPER; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LUNG LAVAGE; MICROBIOLOGY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; NELFINAVIR; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECI; PYRIDINES; PYRONES; RITONAVIR; SAQUINAVIR;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS;

EID: 33751368021     PISSN: 10665234     EISSN: 15507408     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2006.00206.x     Document Type: Conference Paper

References (15)

1. Atzori, C., Angeli, E., Mainini, A., Agostoni, F., Micheli, V. & Cargnel, A. 2000. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii. J. Infect. Dis., 181:1629-1634.
2. Atzori, C. & Cargnel, A. 2002. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii. J. Infect. Dis., 185:1692-1693.
3. Atzori, C., Fantoni, G., Valerio, A. & Cargnel, A. 2001. In vitro activity of amprenavir against Pneumocystis carinii. Int. J. Antimicrob. Agents, 18:271-273.
4. Atzori, C., Valerio, A., Fantoni, G., Tronconi, E. & Cargnel, A. 2002. Effect of LPV/r and Atazanavir on P. carinii in vitro growth. Abstract M1157. Abstracts of the 42th Annual Meetings of ICAAC, San Diego, CA. 400 p.
5. Atzori, C., Villani, P., Regazzi, M., Maruzzi, M. & Cargnel, A. 2003. Detection of intrapulmonary concentration of lopinavir in an HIV-infected patient. AIDS, 17:1710-1711.
6. Boehringer Ingelheim. 2002. Tipranavir, Investigator's Brochure. Boehringer Ingelheim, Ingelheim, Germany..
7. Cassone, A., De Bernardis, F., Torosantucci, A., Tacconelli, E., Tumbarello, M. & Cauda, R. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis., 180:448-453.
8. Conte, J., Duncan, S., McKenna, E. & Zurlinden, E. 1999. Effect of gender and race on the pharmacokinetycs of pentamidine in HIV-infected patients. Clin. Pharmacokinet., 17:293-299.
9. Derouin, F. & Santillana-Hayat, M. 2002. Anti-Toxoplasma activity of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro. Antimicrob. Agents Chemother., 44:2575-2577.
10. Korting, H. C., Schaller, M., Eder, G., Hamm, G., Bohmer, U. & Hube, B. 1999. Effects of the immunodeficiency virus (HIV-1) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-1-infected patients. Antimicrob. Agents Chemother., 43:2038-2042.
11. Lu, J. J., Bartlett, M. S., Smith, J. W. & Lee, C.-H. 1995. Typing of Pneumocystis carinii strains with type-specific oligonucleotide probes derived from nucleotide sequences of internal transcribed spacers of rRNA genes. J. Clin. Microbiol., 33:2973-2977.
12. Mazza, F., Tronconi, E., Valerio, A., Cargnel, A. & Atzori, C. 2006. The non-peptidic HIV protease inhibitor tipranavir modulates Pneumocystis in vitro growth. Abstract THPE0051, XVI AIDS 2006, Toronto, Canada.
13. Morris, A., Wachter, R. M., Luce, J., Turner, J. & Huang, L. 2003. Improved survival with highly active antiretroviral therapy in HIV infected patients with severe Pneumocystis carinii pneumonia. AIDS, 17:73-80.
14. Roche. Fortovases®, Saquinavir-SGC. 1999. Monografia Roche Registration Limited, Hertfordshire, UK..
15. Roche. Viracepts®, Nelfinavir. 1997. Product Monograph. F. Hoffmann-La Roche Ltd , Basel, Switzerland.